Johnson & Johnson (JNJ) volatility low, confirms 'preliminary' talks with Actelion

November 25, 2016 12:12 PM EST

Find out which companies are about to raise their dividend well before the news hits the Street with's Dividend Insider Elite. Sign-up for a FREE trial here.

Johnson & Johnson (NYSE: JNJ) current 30-day call option implied volatility is at 13, compared to a one month ago level of 14 into confirming in a press release that it is engaged in preliminary discussions with Actelion Pharmaceuticals (ALIOF) regarding a potential transaction.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Options, Trader Talk

Related Entities


Add Your Comment